Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Northwest Biotherapeutics (NWBO) Goodwill & Intangibles (2020 - 2025)

Northwest Biotherapeutics (NWBO) has 6 years of Goodwill & Intangibles data on record, last reported at $1.9 million in Q3 2025.

  • For Q3 2025, Goodwill & Intangibles changed 0.0% year-over-year to $1.9 million; the TTM value through Sep 2025 reached $1.9 million, changed 0.0%, while the annual FY2024 figure was $1.9 million, 0.0% changed from the prior year.
  • Goodwill & Intangibles reached $1.9 million in Q3 2025 per NWBO's latest filing, roughly flat from $1.9 million in the prior quarter.
  • Across five years, Goodwill & Intangibles topped out at $1.9 million in Q1 2021 and bottomed at $1.9 million in Q1 2021.
  • Average Goodwill & Intangibles over 5 years is $1.9 million, with a median of $1.9 million recorded in 2021.
  • The widest YoY moves for Goodwill & Intangibles: up 0.0% in 2021, down 1.44% in 2021.
  • A 5-year view of Goodwill & Intangibles shows it stood at $1.9 million in 2021, then changed by 0.0% to $1.9 million in 2022, then changed by 0.0% to $1.9 million in 2023, then changed by 0.0% to $1.9 million in 2024, then changed by 0.0% to $1.9 million in 2025.
  • Per Business Quant database, its latest 3 readings for Goodwill & Intangibles were $1.9 million in Q3 2025, $1.9 million in Q2 2025, and $1.9 million in Q1 2025.